JPL Wealth Management’s BridgeBio Pharma BBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-25
Closed -$1.86K – 1672
2026
Q2
$1.86K Hold
25
– – ﹤0.01% 1100
2026
Q1
$1.86K Buy
+25
New +$1.81K ﹤0.01% 1001
2025
Q4
– Sell
-25
Closed -$1.3K – 217
2025
Q3
$1.3K Buy
+25
New +$1.22K ﹤0.01% 956

Other funds holding BBIO

JPL Wealth Management's BBIO Position: Q3 2026 in Review

JPL Wealth Management sold out of BridgeBio Pharma (BBIO) in Q3 2026, closing a stake of 25 shares — an estimated $1.86K sold.

JPL Wealth Management first reported a position in BBIO in Q3 2025 and held it in 3 quarters. The position peaked at $1.86K in Q2 2026. 471 funds tracked by Wall St. Rank hold BBIO as of Q3 2026.

  • JPL Wealth Management reported no remaining BridgeBio Pharma position as of Q3 2026 after selling out during the quarter.
  • JPL Wealth Management sold 25 BridgeBio Pharma shares in Q3 2026, an estimated $1.86K.
  • JPL Wealth Management first reported a position in BridgeBio Pharma in Q3 2025 and held it in 3 quarters.
  • JPL Wealth Management's BridgeBio Pharma position peaked at $1.86K in Q2 2026.
  • 471 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q3 2026.

Based on JPL Wealth Management's 13F filing for Q3 2026, filed 13 Nov 2026.